We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2503:TSEKirin Holdings Co. Ltd. Analysis

Data as of 2026-05-26 - not real-time

HK$0.22

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical indicators show a mixed picture: the 20‑day SMA sits just above the 50‑day SMA, suggesting a slight short‑term bias, yet both remain far below the 200‑day SMA, placing the stock in a neutral long‑term trend. The 14‑day RSI is around 38, hinting at modest oversold pressure but not a decisive reversal signal, while the MACD line is below its signal line, reinforcing a bearish momentum stance. Volume is trending upward, which could provide support for price moves, but the 30‑day volatility exceeds 150% and the historical max drawdown is over 90%, underscoring extreme price swings.
On the fundamentals side, the company trades at a price‑to‑book of roughly 0.25 and a price‑to‑sales below 1, indicating a very cheap valuation relative to its balance sheet. However, earnings are deeply negative with gross, operating, and net margins all in the negative range, cash flow is deteriorating, and debt‑to‑equity exceeds 12, reflecting a precarious financial footing. No dividend is paid and analyst coverage is absent, leaving investors without guidance. In this context, the stock appears undervalued from a pure asset perspective but carries substantial earnings and liquidity risk, especially given its concentration in the Chinese construction sector and the broader regulatory environment.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Negative earnings and cash flow
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Extremely low price‑to‑book valuation
  • Increasing trading volume
  • Continued financial losses

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential for turnaround given cheap asset base
  • Low beta indicating limited market‑wide exposure
  • Strategic exposure to China's infrastructure spending

Key Metrics & Analysis

Financial Health

Revenue Growth-39.70%
Profit Margin-8.58%
ROE-7.07%
ROA-1.34%
Debt/Equity12.56
P/B Ratio0.2
Op. Cash FlowHK$-164247008
Free Cash FlowHK$-145678496
Industry P/E30.1

Technical Analysis

TrendNeutral
RSI38.9
SupportHK$0.18
ResistanceHK$0.39
MA 20HK$0.27
MA 50HK$0.27
MA 200HK$0.59
MACDBearish
VolumeIncreasing
Fear & Greed Index91.05

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.08
Volatility157.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.